Ignite Creation Date:
2024-05-05 @ 6:34 PM
Last Modification Date:
2024-10-26 @ 9:34 AM
Study NCT ID:
NCT00507468
Status:
COMPLETED
Last Update Posted:
2009-11-03
First Post:
2007-07-22
Brief Title:
Autologous Bone Marrow Transplanted Via Transendocardial Catheter to Chronic Myocardial Infarct Border Zone
Sponsor:
BioCardia Inc
Organization:
BioCardia Inc
Study Overview
Official Title:
Autologous Bone Marrow Transplanted Via Transendocardial Catheter to Chronic Myocardial Infarct Border Zone
Status:
COMPLETED
Status Verified Date:
2009-11
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
TABMMI
Brief Summary:
The object of this open-labeled uncontrolled pilot study was to investigate the safety and feasibility of percutaneously transplanting autologous bone marrow ABM cells into the myocardium using the helical needle transendocardial TE delivery system in stable coronary patients with ventricular dysfunction due to chronic myocardial infarction MI
A secondary goal was to assess the possibility that such cell injections could improve ejection fraction EF
A secondary goal was to assess the possibility that such cell injections could improve ejection fraction EF
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None